Novartis AG (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 144   

Articles published

NVS 95.29 +0.68 (0.72%)
price chart
Novartis' (NVS) Signifor Wins EU Approval For Rare Hormonal Disorder
Novartis AG (ADR) (NYSE:NVS) announced before US markets opened for trading Monday that the European Commission has approved its drug Signifor for the treatment of a rare hormonal disorder that is believed to affect about 1-2 in every 10,000 ...
Related articles »  
Novartis AG (ADR) (NYSE:NVS) Updates On FDA Review Of LBH589
Novartis AG (ADR) (NYSE:NVS) has offered an update on the progress of the review of its investigation drug for a condition known as multiple myeloma.
FDA Delays Approval For Novartis AG (NVS) Myeloma Drug  Bidness ETC
Related articles »  
Foreign Companies News: Rio Tinto plc (ADR) (RIO), Novartis AG (ADR) (NVS ...
Rio Tinto plc (ADR) (NYSE:RIO), the world's second-biggest mining company, is now seeing iron ore trading close to $100 per metric ton.
Related articles »  
Google Inc (GOOGL) and Novartis AG (ADR) (NVS) Join Hands to Develop ...
Tech giants are now focusing excessively on wearables that can help users to track health-related issues. According to a report by Bloomberg, Google Inc (NASDAQ:GOOGL) and Novartis AG (ADR) (NYSE:NVS) now have a deal according to which both ...
Related articles »  
Novartis Posts Strong Third-Quarter Results; Cost-Cutting Efforts Pay Off
Novartis AG (ADR) (NVS) posted upbeat financial and operational results for the third quarter of its fiscal year (3QFY14) today before markets opened.
Novartis (NVS) Beats on Q3 Earnings, Revenues; Keeps View - Analyst Blog  Nasdaq
Related articles »  
Healthcare Stocks To Watch Today: Actavis (ACT), Novartis (NVS), Merck (MRK ...
The decline came on a downgrade by Credit Suisse Group AG (ADR) (NYSE:CS) and due to other sell-side analysts giving the stock an overall Hold rating.
Why Array Biopharma (ARRY) Stock Surged Yesterday
Array Biopharma Inc (NASDAQ:ARRY) stock rallied 22.7% in extended trading on Wednesday after it announced that it had entered into a new agreement with Novartis AG (ADR) (NYSE:NVS). The deal will allow Array to regain the marketing and ...
Why Delta Air Lines, Hawaiian Electric Industries, and Array BioPharma are 3 ...  Investorplace.com
Array BioPharma, Inc. (NASDAQ:ARRY) Unexpectedly Leads Biotech With ...  StreetWise Report
Related articles »  
How To Make Money With Generics and Diagnostics [Novartis AG (ADR), Gilead ...
make-money The concept that generic and specialty pharmaceutical drugs cannot command pricing power and growth is a misunderstanding, according to Director and Senior Analyst Rohit Vanjani of Oppenheimer and Co.
Related articles »  
Novartis (NVS) Receives CHMP's Approval For Psoriasis Drug
Novartis AG (ADR) (NYSE:NVS) announced today that secukinumab has received positive feedback from the European Medical Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) for the treatment of moderate-to-severe plaque ...
Related articles »  
Novartis Releases Positive Phase 3 Results For Psoriatic Arthritis Drug
Novartis AG (ADR) (NVS) today released top line results for two late-stage pivotal studies, which evaluated its novel drug secukinumab as a treatment for psoriatic arthritis (PsA).
Related articles »